1h Free Analyst Time
The publisher has been monitoring the anticoagulant reversal drugs market and it is poised to grow by $877.37 mn during 2022-2026 progressing at a CAGR of 12.27% during the forecast period. The report on the anticoagulant reversal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of coagulation disorders, increase in hip and knee surgeries, and strategic alliances.
The anticoagulant reversal drugs market analysis includes the distribution channel segment and geographic landscape.
The anticoagulant reversal drugs market is segmented as below:
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the recent developments as one of the prime reasons driving the anticoagulant reversal drugs market growth during the next few years. Also, increasing research and development activities and new therapeutic applications and increasing focus toward emerging economies will lead to sizable demand in the market.
The report on anticoagulant reversal drugs market covers the following areas:
- Anticoagulant reversal drugs market sizing
- Anticoagulant reversal drugs market forecast
- Anticoagulant reversal drugs market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anticoagulant reversal drugs market vendors that include Amboss GmbH, Amneal Pharmaceuticals Inc., AstraZeneca Plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Covis Pharma BV, CSL Ltd., GoodRx Holdings Inc., Midas Pharma GmbH, and Pfizer Inc. Also, the anticoagulant reversal drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2. Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3. Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4. Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5. Market Segmentation by Distribution Channel
5.1 Market segments
Exhibit 24: Chart on Distribution Channel - Market share 2021-2026 (%)
Exhibit 25: Data Table on Distribution Channel - Market share 2021-2026 (%)
5.2 Comparison by Distribution Channel
Exhibit 26: Chart on Comparison by Distribution Channel
Exhibit 27: Data Table on Comparison by Distribution Channel
5.3 Hospital pharmacy - Market size and forecast 2021-2026
Exhibit 28: Chart on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
5.4 Retail pharmacy - Market size and forecast 2021-2026
Exhibit 32: Chart on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Retail pharmacy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Retail pharmacy - Year-over-year growth 2021-2026 (%)
5.5 Online pharmacy - Market size and forecast 2021-2026
Exhibit 36: Chart on Online pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Online pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Online pharmacy - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Online pharmacy - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Distribution Channel
Exhibit 40: Market opportunity by Distribution Channel ($ million)
6. Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7. Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.9 Canada - Market size and forecast 2021-2026
Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 China - Market size and forecast 2021-2026
Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
7.12 France - Market size and forecast 2021-2026
Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%)
7.13 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)
8. Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9. Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business
10. Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 Amboss GmbH
Exhibit 93: Amboss GmbH - Overview
Exhibit 94: Amboss GmbH - Product / Service
Exhibit 95: Amboss GmbH - Key offerings
10.4 Amneal Pharmaceuticals Inc.
Exhibit 96: Amneal Pharmaceuticals Inc. - Overview
Exhibit 97: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 98: Amneal Pharmaceuticals Inc. - Key news
Exhibit 99: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 100: Amneal Pharmaceuticals Inc. - Segment focus
10.5 AstraZeneca Plc
Exhibit 101: AstraZeneca Plc - Overview
Exhibit 102: AstraZeneca Plc - Product / Service
Exhibit 103: AstraZeneca Plc - Key news
Exhibit 104: AstraZeneca Plc - Key offerings
10.6 Bausch Health Companies Inc.
Exhibit 105: Bausch Health Companies Inc. - Overview
Exhibit 106: Bausch Health Companies Inc. - Business segments
Exhibit 107: Bausch Health Companies Inc. - Key news
Exhibit 108: Bausch Health Companies Inc. - Key offerings
Exhibit 109: Bausch Health Companies Inc. - Segment focus
10.7 Boehringer Ingelheim International GmbH
Exhibit 110: Boehringer Ingelheim International GmbH - Overview
Exhibit 111: Boehringer Ingelheim International GmbH - Business segments
Exhibit 112: Boehringer Ingelheim International GmbH - Key news
Exhibit 113: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 114: Boehringer Ingelheim International GmbH - Segment focus
10.8 Covis Pharma BV
Exhibit 115: Covis Pharma BV - Overview
Exhibit 116: Covis Pharma BV - Product / Service
Exhibit 117: Covis Pharma BV - Key offerings
10.9 CSL Ltd.
Exhibit 118: CSL Ltd. - Overview
Exhibit 119: CSL Ltd. - Business segments
Exhibit 120: CSL Ltd. - Key news
Exhibit 121: CSL Ltd. - Key offerings
Exhibit 122: CSL Ltd. - Segment focus
10.10 GoodRx Holdings Inc.
Exhibit 123: GoodRx Holdings Inc. - Overview
Exhibit 124: GoodRx Holdings Inc. - Product / Service
Exhibit 125: GoodRx Holdings Inc. - Key offerings
10.11 Midas Pharma GmbH
Exhibit 126: Midas Pharma GmbH - Overview
Exhibit 127: Midas Pharma GmbH - Product / Service
Exhibit 128: Midas Pharma GmbH - Key offerings
10.12 Pfizer Inc.
Exhibit 129: Pfizer Inc. - Overview
Exhibit 130: Pfizer Inc. - Product / Service
Exhibit 131: Pfizer Inc. - Key news
Exhibit 132: Pfizer Inc. - Key offerings
11. Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 133: Inclusions checklist
Exhibit 134: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 135: Currency conversion rates for US$
11.4 Research methodology
Exhibit 136: Research methodology
Exhibit 137: Validation techniques employed for market sizing
Exhibit 138: Information sources
11.5 List of abbreviations
Exhibit 139: List of abbreviations
List of ExhibitsExhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Distribution Channel - Market share 2021-2026 (%)
Exhibits 25: Data Table on Distribution Channel - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Distribution Channel
Exhibits 27: Data Table on Comparison by Distribution Channel
Exhibits 28: Chart on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Retail pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Retail pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Online pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Online pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Online pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Online pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by Distribution Channel ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 82: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits 84: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits 85: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits 86: Market opportunity By Geographical Landscape ($ million)
Exhibits 87: Impact of drivers and challenges in 2021 and 2026
Exhibits 88: Overview on Criticality of inputs and Factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Vendors covered
Exhibits 92: Matrix on vendor position and classification
Exhibits 93: Amboss GmbH - Overview
Exhibits 94: Amboss GmbH - Product / Service
Exhibits 95: Amboss GmbH - Key offerings
Exhibits 96: Amneal Pharmaceuticals Inc. - Overview
Exhibits 97: Amneal Pharmaceuticals Inc. - Business segments
Exhibits 98: Amneal Pharmaceuticals Inc. - Key news
Exhibits 99: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits 100: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits 101: AstraZeneca Plc - Overview
Exhibits 102: AstraZeneca Plc - Product / Service
Exhibits 103: AstraZeneca Plc - Key news
Exhibits 104: AstraZeneca Plc - Key offerings
Exhibits 105: Bausch Health Companies Inc. - Overview
Exhibits 106: Bausch Health Companies Inc. - Business segments
Exhibits 107: Bausch Health Companies Inc. - Key news
Exhibits 108: Bausch Health Companies Inc. - Key offerings
Exhibits 109: Bausch Health Companies Inc. - Segment focus
Exhibits 110: Boehringer Ingelheim International GmbH - Overview
Exhibits 111: Boehringer Ingelheim International GmbH - Business segments
Exhibits 112: Boehringer Ingelheim International GmbH - Key news
Exhibits 113: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 114: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 115: Covis Pharma BV - Overview
Exhibits 116: Covis Pharma BV - Product / Service
Exhibits 117: Covis Pharma BV - Key offerings
Exhibits 118: CSL Ltd. - Overview
Exhibits 119: CSL Ltd. - Business segments
Exhibits 120: CSL Ltd. - Key news
Exhibits 121: CSL Ltd. - Key offerings
Exhibits 122: CSL Ltd. - Segment focus
Exhibits 123: GoodRx Holdings Inc. - Overview
Exhibits 124: GoodRx Holdings Inc. - Product / Service
Exhibits 125: GoodRx Holdings Inc. - Key offerings
Exhibits 126: Midas Pharma GmbH - Overview
Exhibits 127: Midas Pharma GmbH - Product / Service
Exhibits 128: Midas Pharma GmbH - Key offerings
Exhibits 129: Pfizer Inc. - Overview
Exhibits 130: Pfizer Inc. - Product / Service
Exhibits 131: Pfizer Inc. - Key news
Exhibits 132: Pfizer Inc. - Key offerings
Exhibits 133: Inclusions checklist
Exhibits 134: Exclusions checklist
Exhibits 135: Currency conversion rates for US$
Exhibits 136: Research methodology
Exhibits 137: Validation techniques employed for market sizing
Exhibits 138: Information sources
Exhibits 139: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global anticoagulant reversal drugs market: Amboss GmbH, Amneal Pharmaceuticals Inc., AstraZeneca Plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Covis Pharma BV, CSL Ltd., GoodRx Holdings Inc., Midas Pharma GmbH, and Pfizer Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is recent developments.`
According to the report, one of the major drivers for this market is the increasing prevalence of coagulation disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amboss GmbH
- Amneal Pharmaceuticals Inc.
- AstraZeneca Plc
- Bausch Health Companies Inc.
- Boehringer Ingelheim International GmbH
- Covis Pharma BV
- CSL Ltd.
- GoodRx Holdings Inc.
- Midas Pharma GmbH
- Pfizer Inc.
